| Literature DB >> 34863887 |
Maximilian Marhold1, Gero Kramer2, Michael Krainer3, Clémentine Le Magnen4.
Abstract
Prostate cancer (PCa) is the most common non-cutaneous cancer in men in Europe and is predicted to exhibit declining mortality in the European Union (EU) due to various recent improvements in treatment. The goal of this short review is to give insight into the European treatment landscape of PCa, while focusing on improvements in care.Entities:
Keywords: Europe; Prostate cancer; Treatment
Mesh：
Year: 2021 PMID： 34863887 DOI： 10.1016/j.canlet.2021.11.033
Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679